BusinessPROVECTUS ANNOUNCES RESULTS FROM MECHANISM OF ACTION STUDY OF TOPICAL PH-10 FOR THE TREATMENT OF PSORIASISBy Nasdaq OMXNov 30, 2017, 11:00 AM UTC
BusinessRitter Pharmaceuticals, Inc. Prices $23,000,000 Public OfferingBy Nasdaq OMXSep 29, 2017, 12:00 PM UTC
